Fmoc-L-allo-Thr(tBu)-OH

Fmoc-L-allo-Thr(tBu)-OH is an Fmoc-protected allo-threonine derivative featuring a stereogenic side chain characteristic of the allo configuration and a tert-butyl-protected hydroxyl group on the threonine side chain. The molecule contains an N-(9H-fluoren-9-ylmethoxycarbonyl) group for stable base-compatible amine protection during peptide assembly, while the carboxylic acid remains available for amide bond formation and subsequent coupling chemistry. The tBu ether masks the side-chain alcohol to suppress undesired O-acylation and to control chemoselectivity during peptide synthesis, with deprotection typically aligned with standard acid-labile protecting-group strategies. The combination of a chiral amino acid backbone, an orthogonally protected side-chain hydroxyl, and a reactive C-terminal acid makes the compound suitable as a defined stereochemical building block and as a chiral intermediate for downstream amino acid derivatization.

1. Peptide Synthesis

Fmoc-L-allo-Thr(tBu)-OH is applied in solid-phase peptide synthesis and solution-phase peptide coupling where a protected threonine residue with allo stereochemistry is required for stereocontrolled sequence construction. The Fmoc group enables iterative N-terminal deprotection and re-coupling, while the free carboxylic acid participates in standard peptide coupling to form the backbone amide. The side-chain tert-butyl ether protects the hydroxyl functionality from premature acylation, supporting clean incorporation of the residue into longer peptides and minimizing side reactions such as O-alkylation or side-chain cross-reactivity. The resulting peptide products can be carried forward to selective side-chain unveiling under acid conditions to generate a defined threonine-like hydroxyl handle for subsequent functionalization, biochemical assays, or further conjugation. The allo stereochemical identity supports peptide analog studies where stereochemistry at the threonine center influences conformational preferences and molecular recognition.

2. Side-Chain Functionalization

Fmoc-L-allo-Thr(tBu)-OH serves as a controlled precursor for side-chain hydroxyl derivatization in amino acid modification workflows and peptidomimetic construction. The tert-butyl-protected alcohol provides a protected, orthogonally addressable functional group that can be unmasked when side-chain reactivity is desired, enabling formation of O-linked derivatives such as ethers, esters, or activated hydroxyl intermediates. The allo-threonine stereochemistry can be retained through subsequent transformations, supporting structure-function investigations where hydroxyl placement and stereochemical arrangement affect hydrogen-bonding patterns and local geometry. The protected amino acid format also supports sequential protection strategies, allowing the hydroxyl to remain dormant during peptide assembly and to be activated later for conjugation to probes, linkers, or scaffolds. Downstream derivatives generated from the deprotected side chain can be used to tune solubility, binding interactions, and chemical handles for analytical or synthetic follow-on steps.

3. Chiral Building Blocks

Fmoc-L-allo-Thr(tBu)-OH is utilized as a chiral amino acid intermediate for enantio- and diastereoselective synthesis planning in synthetic organic chemistry. The molecule's stereogenic centers and protected functional groups provide a stable platform for constructing stereochemically defined fragments that can be carried into peptide building block preparation or other chiral scaffold assembly. The Fmoc-protected amine supports controlled N-functionalization while reducing undesired amine reactivity, and the tBu ether masks the side-chain hydroxyl to maintain chemoselectivity during intermediate transformations. The C-terminal acid enables conversion into activated esters or coupling-ready derivatives in manufacturing-relevant workflows, supporting consistent downstream incorporation into amide-forming steps. The compound's stereochemical definition makes it suitable for producing labeled or non-labeled chiral analogs used to probe stereochemical effects in molecular design and SAR studies.

4. Bioconjugation Chemistry

Fmoc-L-allo-Thr(tBu)-OH is used in bioconjugation and chemical biology workflows that require a protected amino acid residue bearing a latent hydroxyl functional group. The protected side-chain alcohol can be revealed under conditions compatible with peptide or linker chemistry, after which the hydroxyl can participate in controlled coupling to generate O-linked attachments to biomolecular scaffolds. The Fmoc group supports preparation of peptides or peptide-like conjugates where the amino acid is incorporated at a defined position, enabling site-specific placement of the conjugation handle within a larger construct. The allo-threonine stereochemistry can influence local conformation around the conjugation site, which may affect conjugate stability, recognition by binding partners, or behavior in biochemical assays without requiring changes to the overall conjugation strategy. The resulting functionalized peptides and conjugates can serve as research tools for mapping interactions, evaluating labeling chemistries, and generating defined biomolecule-modified materials.

5. Pharmaceutical Manufacturing

Fmoc-L-allo-Thr(tBu)-OH is relevant to pharmaceutical manufacturing and fine chemical production where protected amino acid building blocks are incorporated into peptide intermediates under controlled, scalable synthetic conditions. The Fmoc protection strategy supports orthogonal handling during peptide assembly, with base-labile N-deprotection that is compatible with common process conditions used to build peptide sequences. The tert-butyl ether protects the side-chain hydroxyl to reduce side reactions during coupling cycles, improving reproducibility of intermediate profiles and supporting downstream deprotection steps aligned with standard manufacturing protecting-group logic. The defined chiral amino acid structure enables consistent stereochemical outcomes in peptide intermediate preparation, which is essential for producing stereochemically specified peptide materials and reference standards. The compound's protected functional-group pattern also supports conversion into coupling-ready intermediates and facilitates integration into controlled process routes for peptide-based active ingredient candidates and related peptide-derived materials.

1. High fat diet and GLP-1 drugs induce pancreatic injury in mice

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

4. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes